Vaccine Vials Market Size, Share & Trends Analysis Report By Type (Single Dose, Multi Dose), By Material (Glass, Polymer) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Vaccine Vials Market Size

The global vaccine vials market size was valued at USD 7.54 billion in 2025 and is projected to grow from USD 8.71 billion in 2026 to USD 27.52 billion by 2034, registering a CAGR of 15.47% during the forecast period from 2026 to 2034. North America dominated the vaccine vials market with a market share of 36.8% in 2025.

The invention of vaccines has revolutionized the healthcare scenario across the world. Vaccines strengthen the immune system by exposing it to weaker pathogens. The enhanced immune system then protects the human body from infections and diseases. The commercially available vaccines are packaged in vials or ampoules and then administered through injections. The vaccine manufacturers prefer small vials for packaging to produce a large amount of vaccine. At the same time, vaccines are administered in smaller dosages than other drugs, making smaller-sized vails a better packaging option. Also, vaccine vials are available in either plastic or glass material. Furthermore, the vaccine vials could differ in design depending upon their use, including single or multiple doses. The market players offer a wide variety of vials for vaccine packaging.

Type Insights

The market is segmented into single-dose and multi-dose. The multi-dose segment is the highest contributor to the market and is projected to grow at a CAGR of 15.62% over the forecast period. A multi-dose vial is packaged with more than one dose of medication. The CDC recommends that multi-dose vials be dedicated to just one patient whenever possible. However, it still acknowledges the possibility that a vial would need to be used on many patients, which is crucial when the business experiences drug shortages. Multi-dose vials for the vaccine have some benefits, such as multiple doses can be administered from a single vial, cost-effectiveness as required less storage, etc. As per WHO guidelines, opened vials can be used in subsequent immunization sessions, in different sites, for up to 28 days. This provides the advantage of using multi-dose vaccine vials in National immunization programs. Considering the future need for mass vaccination, the multi-dose vaccine vials segment is estimated to register significant growth in the market.

Single-dose vaccine formats show some benefits over multi-dose vials. A single patient will utilize a single-dose or single-use vial for a single case, injection, or procedure when it is meant for parenteral delivery, such as an infusion or injection. One of the significant advantages of single-dose vials is that each vaccine dose remains sealed and protected until it is ready for administration, providing additional safety to patients by decreasing the chances of contamination and waste. Considering the current COVID-19 pandemic, demand for single-dose vaccine vials is expected to rise at a healthy rate in upcoming years.

Request Customizationto receive a tailored report.

Material Insights

The market is segmented into glass and polymer. The glass segment owns the highest market share and is estimated to grow at a CAGR of 15.77% during the forecast period. Glass vials are the preferred packaging material for vaccines, as the interaction of the drug with glass is comparatively significantly less. Regulatory bodies for packaging and storage of vaccines for a longer duration authorize glass vials. Different types of glass vials are used for vaccines. 2 ml Type1 tubular glass vials and 3 ml molded vials are most preferred for vaccines currently. However, the demand for molded glass Type 1 vial is also increasing, especially for multi-dose vaccines. 10 ml, 20 ml, 30 ml, and 50 ml molded glass vials can be used for multi-dose vaccinations as an immediate solution in case of a shortage of vials. Admitting that the demand for vials is likely to go up significantly in billions after the commercialization of the COVID-19 vaccine, many glass vials manufacturers have tripled their manufacturing capacity.

The polymer segment is growing at a healthy rate over the forecast period. Considering the global demand for vaccine vials, there are chances of a shortage of glass vials, polymer-based vials, on the other hand, provide a better alternative to overcome such problems in the future. The packaging of vaccines is appropriate for polymer-based vials due to their exceptionally low leachability and extractability, low reactivity surface, non-polar nature, and widespread global regulatory compliance. This material provides high purity, and its inert nature prevents its reactions with drugs. Furthermore, this bottle offers additional benefits like being portable, lightweight, crack resistant, and not breaking easily, decreasing the chances of contamination.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most substantial shareholder in the global vaccine vials market and is estimated to grow at a CAGR of 15.53% during the forecast period. Due to an increase in patients and rising healthcare costs for both public and private healthcare actors in North America, the market for vaccine vials is expanding rapidly. The growing number of compounding laboratories and research institutes in the United States is boosting the demand for these vaccine vials. Furthermore, the increasing number of collaborations to achieve innovative packaging technology boosts the market. The growing incidence of infectious and non-infectious diseases and the rising number of clinical studies translate into greater demand for these vials. In addition, the government is backing the promotion of pharmaceutical, medical, and biotechnological research, which is projected to work in favor of the market. The presence of several significant market players in the North American region that hold a considerable share of the market favors the growth of the vaccine vials.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Vaccine Vials Market Trends

Europe is estimated to grow at a CAGR of 15.09% over the forecast period. The European region is one of the most prominent regions for the pharmaceutical industry due to its sizeable pharmaceutical manufacturing base and the ability to introduce technological advancements to pharmaceutical packaging. Furthermore, vendors in the market are trying to help as much as possible during the coronavirus outbreak. Vendors are supplying their products, from glass tubing for diagnostic test kits to vials for clinical drug trials for vaccines to providing glass packaging to help fill the gap for the projected drug shortages. This, in turn, boosts the market of vaccine vials. The rising incidence of fatal diseases is the primary factor escalating market growth. Furthermore, demand for effective medical procedures and massive concerns over patients' health and safety are the major factors, among others, driving the development of the market of vaccine vials. In addition, Germany held the largest share among the European countries and is expected to remain dominant over the forecast period. The presence of several prominent market players in the Europe region holds a massive share of the market and favors the growth of the vaccine vials market.

Asia Pacific Vaccine Vials Market Trends

The Asia-Pacific vaccine vials market size is expected to grow the fastest. The rapidly growing pharmaceutical industry across the region and the high demand for vaccine vials are arising majorly from densely populated countries. Owing to these factors, this market will have a tremendous opportunity. Moreover, the growing complexity of drugs and the increasing diseases, such as diabetes, are anticipated to drive the growth of vials, primarily driven by increased consumption from emerging markets, such as China and India. India is one of the top producers and exporters of pharmaceutical goods worldwide. As stated by the IBEF, the packaging industry in the country constitutes about 4% of the worldwide packaging industry. In addition, the government is witnessing the growing purchasing power of India's middle-class population in healthcare services, predominantly medicines. Likewise, numerous factors, such as innovations, augmented R&D spending, the increasing trend of contract packaging, and the development in the generics market, are anticipated to drive the demand for vaccine vials in the country, which drive the regional market growth.

The RoW comprises the Middle East and Africa and Latin America region. In the Latin America region, Brazil appeared as the prominent market for vaccine vials in Latin America. The government initiatives for creating awareness regarding proper healthcare facilities are also bolstering the demand for vaccine vials in the Latin America region. Rapidly aging Latin American countries will go through remarkable growth for the vaccine vials market in the near future. In contrast, due to the expanding healthcare infrastructure, the Middle East and African markets for Egyptian vaccine vials are anticipated to expand steadily during the forecasted period. Rising incidences of Cardiothoracic, Gastrointestinal, Orthopedic, and other diseases requiring proper management in a medical facility across the Gulf Cooperation Council countries drive the growth market of vaccine vials in the Middle East and Africa.

List of Key and Emerging Players in Vaccine Vials Market